Pharmaceutical distribution
- 804.745
- +2.605+0.32%
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
The era of large models in medicine! AI empowers the Industry to press the "accelerator", while the industry still hopes for revolutionary technology to emerge | Medicine Bottoming Series ④
① AI, with its powerful data summarization capabilities, is driving further innovation in the Medical and pharmaceutical fields; ② however, pharmaceutical companies still feel troubled about how to leverage AI in research and development; ③ industry insiders believe that the limitations of technology and the inviolability of ethical and legal responsibilities objectively prevent AI from having the capability to be a responsible entity.
The volatility of Technology stocks has intensified in the short term, waiting for low-buy opportunities after risks are fully released.
Track the entire lifecycle of the main Sector.
The "Technology Carnival" has become a strong catalyst, public funds are gathering to research Computer and high-end manufacturing. Who will be able to capture the next doubling stock?
① Numerous Fund companies are intensifying their research efforts on the Technology Sector, attempting to uncover future investment opportunities in the technology wave, with the Computer Industry companies being the most focused on; ② Several DeepSeek Concept stocks have doubled in price this year, and Institutions believe that technology stocks, particularly those related to DeepSeek, are expected to continue to perform strongly.
Ice and fire coexist! The Technology sector is "hot and spicy," with crowding reaching the ceiling, while these Sectors have fallen into a "cold winter."
①As of today, the total transaction amount of the TMT and Machinery Sector has exceeded 1 trillion for three consecutive days, accounting for over 50% of the market for fifteen consecutive days. ②In terms of valuation, the PE of the Machinery, Electronics, Steel, Computer, Building Materials, and other sectors are at historically high levels. ③The crowding level in the Wind Power, Ship Manufacturing, Textile and Apparel, Tourism and Scenic Spots, Air Transportation, Banks, Coal, Oil and Petrochemical, and Thermal Power sectors is moderate to low.
Similar to 2010, DeepSeek begins the "iPhone4" moment of AI.
SWHY believes that the current stage of AI industry development is very similar to the early days of the Penghua CSI Mobile Internet Index Fund(LOF)-A in 2010, and the emergence of DeepSeek technology has greatly increased the likelihood of AI applications being implemented, similar to the role that the iPhone 4 played in promoting mobile internet applications at that time.
Local governments are keen on DeepSeek, chasing the AI government affairs trend.
1. Jiangyin, known as the first county in China Capital Markets, has seen the DeepSeek application quietly enter its third generation in just two weeks. 2. Currently, the market participants of State-owned Assets Cloud mainly include central state-owned enterprises and local state-owned enterprises, with the former primarily comprising the three major telecom operators and China Electronics Corporation among others. 3. On the other side of the market explosion, with the in-depth application of DeepSeek, data security and privacy protection issues have also attracted attention.
Are Innovative Drugs receiving a New Year's bonus at the start of the year? Support from medical insurance policies may come in multiple ways, and listed companies express that they will "seize the opportunity."
① Two major consultation drafts focus on the pricing and payment of Innovative Drugs, proposing multiple specific innovative mechanisms, further igniting enthusiasm in the Innovative Drugs Industry; ② Industry experts believe that the Class B medical insurance catalog serves as a shot in the arm, but attention should be paid to expanding its Fund pool and further measures to guide insured enthusiasm; ③ Many listed companies have noticed this dynamic and stated they will "closely monitor, actively cooperate in the future, and seize opportunities."
AI Medical has exploded, the Smart Medical Index surged 32% within the month, Hong Kong stocks of Innovative Drugs have also soared, and the first 10 billion-level ETF has been born.
① Since February, the Hong Kong Innovative Drugs Index has increased by 15.99%, and the GF CSI Hong Kong Innovative Drugs Industry ETF has also daily surpassed 10 billion in scale, becoming the first Fund in the All Market to exceed 10 billion in the Hong Kong innovative drug thematic Index; ② The Smart Medical Index has reached an increase of 32.15% this month, with a rise of 72.73% over the past six months; ③ By 2030, the AI market in the Medical and health sector is expected to reach 2 trillion yuan.
Pharmaceutical companies are racing in AI! The leading CRO has acquired an AI company in the oncology field, with another player entering the Sector of large models.
① PHARMARON officially announced yesterday that it has acquired the AI company Haixin Zhihui, which specializes in patient management in the field of oncology, to improve the efficiency of new drug development; ② Many CRO companies have already begun to invest in AI, and investors are bullish on the future potential of this Business; ③ In the past 18 trading days, the CRO Concept has seen a continuous surge.
Who Are China's AI Winners Post-DeepSeek? Goldman Sachs Picks 30 Firms
Brokerage morning meeting highlights: Now is the right time for AI healthcare layout.
In today's Brokerage morning meeting, Sinolink proposed that the layout of AI in healthcare is timely; HTSC expressed a bullish outlook on the product upgrades and commercial breakthroughs of AI applications in China by 2025; China Securities Co.,Ltd. believes that the turning point in the IDC Industry is approaching, and a new cycle is expected to begin.
DeepSeek has emerged, and Chinese Technology stocks have surged! Citibank: the market is not yet overheated.
Citigroup Analyst believes that since the beginning of the year, the QITABANKUAI in China has indeed seen an increase in congestion, primarily due to the rise of technology stocks, which has boosted overall valuations and improved market sentiment. However, if excluding the weight stock Xiaomi Group, it can be found that although the QITABANKUAI in China has a higher congestion compared to other sectors, it is still not the most congested sector, indicating that this sector has not yet overheated.
Express News | Hong Kong Indexes Extend Gains. Alibaba Rises 4%, KuaiShou Surges 7% and Baidu Up 5%
Fully embrace the DeepSeek model! Cloud vendors like Volcano Engine are joining in. Can they "steal" a piece of the computing power pie?
① Volcano Engine Smart General will hold seminars focusing on multi-model deployment and invocation, API invocation of DeepSeek R1 on Volcano Ark, deploying the DeepSeek solution on Volcano Engine, and developing AI applications on the DeepSeek platform. ② Alibaba Cloud, Huawei Cloud, Baidu Cloud, Tencent Cloud, and UCloud have also successively launched the DeepSeek large model on their Cloud Computing Service platforms.
DeepSeek opens a new era of AI, and the curtain rises on "sovereign AI."
In Deutsche Bank's view, DeepSeek is likely to become a "Sputnik moment" for many countries outside the USA. It not only raises security concerns but also showcases the potential for AI development in regions outside the USA, which is likely to increase the pressure on various countries to invest in sovereign AI.
Does DeepSeek lead the reconstruction of valuations for China's technology stocks? Foreign investors: the focus has shifted from risk to potential.
① Market observers believe that the emergence of DeepSeek has led overseas investors to reevaluate the potential and valuation of AI in Chinese Internet companies; ② The launch of DeepSeek not only excites investors but may also accelerate the adoption of AI by businesses and consumers, reducing costs for large-scale enterprises, which is a significant Bullish development for Cloud Computing Service providers like Alibaba and Tencent.
Tech stocks continue to be hot; can edge AI and Siasun Robot&Automation continue to "ride the wave"?
Track the entire lifecycle of the main Sector.
WuXi AppTec leads the surge of Hong Kong stock pharmaceutical shares, while Global Biomedical investment and financing shows signs of recovery.
① The WuXi AppTec system leads the rise of Hong Kong pharmaceutical stocks, which Bullish factors are worth paying attention to? ② Global Biomedical investment and financing has seen some recovery, how do Institutions view it?
Pharmaceutical stocks have become a transitional theme at present, and the performance line may be further valued by the market.
Track the entire lifecycle of the main sector.